Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bcl-2-associated athanogene 2
(
BAG2
) is an important member in the BAG family which is characterized by their property of interaction with a variety of partners involved in modulating the proliferation/death balance. The role of BAG family proteins in
Parkinson's disease
(PD) has not been elucidated. In this study, we demonstrated that overexpressing
BAG2
ameliorates the effects of 1-methyl-4-phenylpyridinium (MPP+) in mitochondrial membrane potential (MMP) collapse, reactive oxygen species (ROS) generation, and mitochondrial release of cytochrome C. However, knockdown of DJ-1 abolished the neuroprotective effects of
BAG2
against MPP+-induced neuronal toxicity. With co-immunoprecipitation and pulldown experiments, we present a direct physical interaction between
BAG2
and DJ-1. Co-expression of BAG-2 together with DJ-1 increased the ratio of dimer/monomer staining intensity at the basal level. Our results indicated that MPP+ treatment leads to the disassociation of the homodimer of DJ-1. When
BAG2
was overexpressed in cells, the homodimer of DJ-1 was increased. Importantly,
BAG2
prevents MPP+-induced monomerization of DJ-1. Thus, our data showed that the neuroprotective effects of
BAG2
are mediated by its interaction with DJ-1, strengthening the link between the BAG proteins and PD-related neurodegeneration.
...
PMID:Bcl-2-associated athanogene 2 prevents the neurotoxicity of MPP+ via interaction with DJ-1. 2560 Aug 33